Judge Balks At ViroPharma's Bid To Halt Vancocin Generics

Law360, Washington (April 19, 2012, 8:52 PM EDT) -- ViroPharma Inc.'s bid to halt the U.S. Food and Drug Administration's recent approval of three generic versions of its gastrointestinal antibiotic Vancocin hit a possible snag Thursday when a Washington federal judge said even a temporary hold on the agency's decision also could cause significant harm to the generics makers.

ViroPharma requested a temporary restraining order to block the FDA's approval of three abbreviated new drug applications for generic Vancocin from Akorn Inc., Alvogen Inc. and Watson Pharmaceuticals Inc., claiming their sudden presence in the market...
To view the full article, register now.